Market news

Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index’s 15.1% and the MSCI ACWI Value Index’s 10.8%. For the first half, the Composite returned 2.3%, versus 11.5% for the Index. The […]

Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Whirlpool Corp (WHR-N) from The Globe and Mail including charting and trades.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Sotera Health Company (NASDAQ:SHC) and its peers.

Sotera Health Company trades at $19.02 per share and has stayed right on track with the overall market, gaining 11.3% over the last six months. At the same time, the S&P 500 has returned 13.1%.

Sotera Health’s second quarter was marked by broad-based growth across its business units, which drove a positive market reaction. Management credited robust demand in both core sterilization (Sterigenics) and isotope supply (Nordion), coupled with improved customer engagement at Nelson Labs, for the outperformance. CEO Alton Shader highlighted that "Sterigenics built on strong momentum from Q1, delivering 7% constant currency revenue growth," while Nordion benefited from favorable Cobalt-60 shi

Detailed price information for Sotera Health Company (SHC-Q) from The Globe and Mail including charting and trades.

Motley Fool Press Release.

Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?

Detailed price information for Sotera Health Company (SHC-Q) from The Globe and Mail including charting and trades.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

Sotera Health Company’s Q2 2026 results, released on August 6, showed revenue rising to US$321.38 million and net income to US$53.64 million, with earnings per share from continuing operations increasing to US$0.19 from US$0.03 a year earlier. Management’s decision to raise full-year guidance after broad-based growth across Sterigenics, Nordion and Nelson Labs highlights improving profitability supported by pricing, volume mix and operational execution. We’ll now examine how Sotera Health’s...

Detailed price information for Sotera Health Company (SHC-Q) from The Globe and Mail including charting and trades.

Healthcare services company Sotera Health (NASDAQ:SHC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 9.2% year on year to $321.4 million. The company expects the full year’s revenue to be around $1.25 billion, close to analysts’ estimates. Its non-GAAP profit of $0.26 per share was 8.7% above analysts’ consensus estimates.

Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis(1) compared to Q2 2025Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025Q2 2026 Adjusted EBITDA(1) increased 10.0%, or 8.7% on a constant currency basisQ2 2026 Adjusted EPS(1) of $0.26, an increase of 30% per diluted shareCompany raises both full-year 2026 net revenues growth outlook to 5.25% - 6.75% and Adjusted EBITDA growth outlook to 5

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Sotera Health Company (SHC) Q2 Earnings Report Preview: What To Look For

O’Keeffe Stevens Advisory, an investment advisory firm, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. During Q2 2026, the market experienced notable dispersion between perceived AI losers and winners. The firm has made investments early in AI infrastructure companies, which yielded gains during market repricing. The second quarter […]

Detailed price information for Interface Inc (TILE-Q) from The Globe and Mail including charting and trades.

CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Compan

Detailed price information for Sotera Health Company (SHC-Q) from The Globe and Mail including charting and trades.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.